This page in Swedish

Johan Jendle

Position: Professor School/office: School of Medical Sciences

Email: am9oYW4uamVuZGxlO29ydS5zZQ==

Phone: +46 709 571257

Room: X4225

Research subject

Medicine

About Johan Jendle

Johan Jendle is a professor in medicine at the institute of Medical Sciences, Örebro University, Sweden. He is also director for the Diabetes Endocrinology and Metabolism Research Center.

Research

His research mainly focuses on diabetes. Ongoing projects aim to develop guidelines on physical activity and diabetes in order to reach good glucose control and optimize physical performance.

Johan Jendle is also involved in new glucose lowering drugs (i.e. SGLT-2 inhibitors and GLP-1 Receptor Agonists), smart insulin pumps, as well as new continuous monitoring systems enabling measurement of glucose and other metabolic factors.

Other research areas and covers research on health economy and diabetes, screening of diabetic retinopathy and new treatment options for obesity with intragastric ballons to support sustainable weight loss and diet fibers to reduce insulin resistance in type 2 diabetes. Other research areas are the associations between ADHD diabetes and cardiovascular disease.

Projects within SARS-CoV2 and diabetes as well as e-Health and diabetes are ongoing.

Prof Jendle has been principal investigator for numerous clinical trials regarding both type 1 and type 2 diabetes. He has authored or co-authored more than 100 papers published in peer-reviewed journals. He is also a regular reviewer and invited speaker at local, national and international scientific meetings.

His research on physical activity and diabetes has led to a number of clinical dissertations and development of different international guidelines within diabetes and sport medicine.

Furthermore Prof Jendle is a member of the working group for continuous glucose monitoring systems in the International Federation of Clinical Chemistry and Laboratory Medicine ( IFCC).

In 2015 Johan Jendle identified a new disease, due to an unique mutation in the gene coding for antidiuretic hormone (AVP) and leading to a specific type of familial diabetes insipidus, now named Jendle's disease.

Teaching

Johan Jendle give lectures and is responsible for the examination at advanced level at the medical school at Örebro University were he is examinator for the school of medicine, 8th term. He is also responsible for national courses in diabetes technology (insulin pumps, glucose sensors). Furthermore, he also gives lectures for diabetic nurses, general practitioners and specialist in endocrinology and diabetology. He is also responsible for the examination of Swedish physicians during their internship.

Collaboration and assignments

Member of the National Board for Internship doctors
Member of the steering group at the medical department, Örebro University Hospital with the responsibility of research and development
Chairman of the National Diabetes Quality Group
Member of the International group IFCC workinggroup on continuous glucose monitoring

CV Johan Jendle

Active projects

Completed projects

Research groups

Publications

Articles in journals

Lind, A. , Cao, Y. , Hesser, H. , Hårdstedt, M. , Jansson, S. P. O. , Lernmark, Å. , Sundqvist, M. , Tevell, S. & et al. (2024). Anxiety, depression and quality of life in relation to SARS-CoV-2 antibodies in individuals living with diabetes during the second wave of COVID-19. Diabetes epidemiology and management, 13. [BibTeX]
Hellman, J. , Hartvig, N. V. , Kaas, A. , Møller, J. B. , Sørensen, M. R. & Jendle, J. (2024). Associations of bolus insulin injection frequency and smart pen engagement with glycaemic control in people living with type 1 diabetes. Diabetes, obesity and metabolism, 26 (1), 301-310. [BibTeX]
Benhalima, K. , Jendle, J. , Beunen, K. & Ringholm, L. (2024). Automated Insulin Delivery for Pregnant Women With Type 1 Diabetes: Where do we stand?. Journal of Diabetes Science and Technology, 18 (6), 1334-1345. [BibTeX]
Koçkaya, G. , Battelino, T. , Petrovski, G. , Jendle, J. , Sármán, B. , Elbarbary, N. , Gökşen, D. , Alharbi, M. & et al. (2024). Clinical perspective on innovative insulin delivery technologies in diabetes management. Frontiers in Endocrinology, 15. [BibTeX]
Eichenlaub, M. , Pleus, S. , Rothenbühler, M. , Bailey, T. S. , Bally, L. , Brazg, R. L. , Bruttomesso, D. , Diem, P. & et al. (2024). Comparator Data Characteristics and Testing Procedures for the Clinical Performance Evaluation of Continuous Glucose Monitoring Systems. Diabetes Technology & Therapeutics, 26 (4), 263-275. [BibTeX]
Eichenlaub, M. , Stephan, P. , Waldenmaier, D. , Pleus, S. , Rothenbühler, M. , Haug, C. , Hinzmann, R. , Thomas, A. & et al. (2024). Continuous Glucose Deviation Interval and Variability Analysis (CG-DIVA): A Novel Approach for the Statistical Accuracy Assessment of Continuous Glucose Monitoring Systems. Journal of Diabetes Science and Technology, 18 (4), 857-865. [BibTeX]
Tian, T. , Aaron, R. E. , DuNova, A. Y. , Jendle, J. H. , Kerr, D. , Cengiz, E. , Drincic, A. , Pickup, J. C. & et al. (2024). Diabetes Technology Meeting 2023. Journal of Diabetes Science and Technology, 18 (5), 1208-1244. [BibTeX]
Sharif, A. , Smith, D. R. , Hellgren, K. & Jendle, J. (2024). Diabetic retinopathy among the elderly with type 2 diabetes: A Nationwide longitudinal registry study. Acta Ophthalmologica, 102 (6), e883-e892. [BibTeX]
Singh, R. , Imberg, H. , Ahmadi, S. S. , Hallström, S. , Jendle, J. , Tengmark, B. , Folino, A. , Marie, E. & et al. (2024). Effects, Safety, and Treatment Experience of Advanced Hybrid Closed-Loop Systems in Clinical Practice Among Adults Living With Type 1 Diabetes. Journal of Diabetes Science and Technology. [BibTeX]
Szafranski, K. , De Pouvourville, G. , Greenberg, D. , Harris, S. , Jendle, J. , Shaw, J. E. , Coaquira Castro, J. , Poon, Y. & et al. (2024). The Determination of Diabetes Utilities, Costs, and Effects Model: A Cost-Utility Tool Using Patient-Level Microsimulation to Evaluate Sensor-Based Glucose Monitoring Systems in Type 1 and Type 2 Diabetes: Comparative Validation. Value in Health, 27 (4), 500-507. [BibTeX]
Klonoff, D. C. , Jendle, J. & Kohn, M. A. (2024). The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose Monitors. Journal of Diabetes Science and Technology, 18 (6), 1346-1361. [BibTeX]
Pleus, S. , Eichenlaub, M. , Eriksson Boija, E. , Fokkert, M. , Hinzmann, R. , Jendle, J. , Klonoff, D. C. , Makris, K. & et al. (2024). The Need for Standardization of Continuous Glucose Monitoring Performance Evaluation: An Opinion by the International Federation of Clinical Chemistry and Laboratory Medicine Working Group on Continuous Glucose Monitoring. Journal of Diabetes Science and Technology. [BibTeX]
Alexander, L. , Cheng-Ting, T. , Åke, L. & Jendle, J. (2024). Type 1 diabetes, celiac disease, and autoimmune thyroiditis autoantibodies in population-based type 2 diabetes patients. Journal of clinical & translational endocrinology, 37. [BibTeX]
Jendle, J. , Buompensiere, M. I. , Ozdemir Saltik, A. Z. , de Portu, S. , Smith-Palmer, J. , Pollock, R. & Cohen, O. (2023). A European Cost-Utility Analysis of the MiniMedTM 780G Advanced Hybrid Closed-Loop System versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People Living with Type 1 Diabetes. Diabetes Technology & Therapeutics, 25 (12), 864-876. [BibTeX]
Klonoff, D. C. , Jendle, J. & Kovatchev, B. (2023). A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings. Journal of Diabetes Science and Technology, 17 (5), 1226-1242. [BibTeX]
Jendle, J. (2023). Analysis of "Glycemic Outcomes During Real-World Hybrid Closed-Loop System Use by Individuals With Type 1 Diabetes in the United States". Journal of Diabetes Science and Technology, 17 (4), 959-961. [BibTeX]
Persson, S. , Nilsson, K. , Karlsdotter, K. , Skogsberg, J. , Gustavsson, S. , Jendle, J. & Steen Carlsson, K. (2023). Burden of established cardiovascular disease in people with type 2 diabetes and matched controls: Hospital-based care, days absent from work, costs, and mortality. Diabetes, obesity and metabolism, 53 (3), 726-734. [BibTeX]
Scherbak, N. N. , Kruse, R. , Nyström, T. & Jendle, J. (2023). Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial. Diabetes & metabolism journal, 47 (5), 668-681. [BibTeX]
Scherbak, N. , Kruse, R. , Nyström, T. & Jendle, J. (2023). Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81). Diabetes & metabolism journal, 47 (6), 882-883. [BibTeX]
Heinemann, L. & Jendle, J. (2023). Language Matters: Connected Pens, Smart Pens, Connected Smart Pens, or Just Digital Pens?. Journal of Diabetes Science and Technology, 17 (4), 875-877. [BibTeX]
Nilsson, K. , Andersson, E. , Persson, S. , Karlsdotter, K. , Skogsberg, J. , Gustavsson, S. , Jendle, J. & Steen Carlsson, K. (2023). Model-based predictions on health benefits and budget impact of implementing empagliflozin in people with type 2 diabetes and established cardiovascular disease. Diabetes, obesity and metabolism, 25 (3), 748-757. [BibTeX]
Jendle, J. , Agvall, B. , Galozy, A. & Adolfsson, P. (2023). Patterns and Predictors Associated With Long-Term Glycemic Control in Pediatric and Young Adult Patients with Type 1 Diabetes. Journal of Diabetes Science and Technology, 17 (5), 1243-1251. [BibTeX]
Jendle, J. , Buompensiere, M. I. , Holm, A. L. , de Portu, S. , Malkin, S. J. P. & Cohen, O. (2022). A Response to: Letter to the Editor with Regard to the Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: A Health Economic Analysis in Sweden. Diabetes Therapy, 13 (5), 1125-1129. [BibTeX]
Dobrosavljevic, M. , Fazel, S. , Du Rietz, E. , Li, L. , Zhang, L. , Chang, Z. , Jernberg, T. , Faraone, S. V. & et al. (2022). Risk prediction model for cardiovascular diseases in adults initiating pharmacological treatment for attention-deficit/hyperactivity disorder. Evidence-Based Mental Health, 25, 185-190. [BibTeX]
Jendle, J. , Eeg-Olofsson, K. , Svensson, A. , Franzen, S. , Lamotte, M. & Levrat-Guillen, F. (2021). Cost-Effectiveness of the FreeStyle Libre^® System Versus Blood Glucose Self-Monitoring in Individuals with Type 2 Diabetes on Insulin Treatment in Sweden. Diabetes Therapy, 12 (12), 3137-3152. [BibTeX]
Jendle, J. H. , Ampudia-Blasco, F. J. , Füchtenbusch, M. & Pozzilli, P. (2021). Dapagliflozin as an Adjunct Therapy to Insulin in Patients with Type 1 Diabetes Mellitus: Efficacy and Safety of this Combination. TouchREVIEWS in endocrinology, 17 (1), 12-20. [BibTeX]
Sterner Isaksson, S. , Bensow Bacos, M. , Eliasson, B. , Thors Adolfsson, E. , Rawshani, A. , Lindblad, U. , Jendle, J. , Berglund, A. & et al. (2021). Effects of nutrition education using a food-based approach, carbohydrate counting or routine care in type 1 diabetes: 12 months prospective randomized trial. BMJ Open Diabetes Research & Care, 9 (1). [BibTeX]
Karlsson, J. , Galavazi, M. , Jansson, S. P. O. & Jendle, J. (2021). Effects on body weight, eating behavior, and quality of life of a low-energy diet combined with behavioral group treatment of persons with class II or III obesity: A 2-year pilot study. Obesity Science & Practice, 7 (1), 4-13. [BibTeX]
Mattsson, S. , Adolfsson, P. , Jendle, J. , Bengtsson, V. & Sparud-Lundin, C. (2021). Empowered by Intertwined Theory and Practice: Experiences From a Diabetes Sports Camp for Physically Active Adults With Type 1 Diabetes. Frontiers in Clinical Diabetes and Healthcare, 2. [BibTeX]
Jendle, J. & Jansson, S. P. O. (2021). Kontinuerlig glukosmätning alternativ vid typ 2-diabetes [Continuous glucose monitoring (CGM) in type 2 diabetes]. Läkartidningen, 118. [BibTeX]
Jendle, J. , Hyötyläinen, T. , Oresic, M. & Nyström, T. (2021). Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride. Cardiovascular Diabetology, 20 (1). [BibTeX]
Da Silva, J. , Bosi, E. , Jendle, J. , Arrieta, A. , Castaneda, J. , Grossman, B. , Cordero, T. L. , Shin, J. & et al. (2021). Real-world performance of the MiniMed™ 670G system in Europe. Diabetes, obesity and metabolism, 23 (8), 1942-1949. [BibTeX]
Sharif, A. , Jendle, J. & Hellgren, K. (2021). Screening for Diabetic Retinopathy with Extended Intervals, Safe and Without Compromising Adherence: A Retrospective Cohort Study. Diabetes Therapy, 12 (1), 223-234. [BibTeX]
Jendle, J. , Ericsson, Å. , Gundgaard, J. , Møller, J. B. , Valentine, W. J. & Hunt, B. (2021). Smart Insulin Pens are Associated with Improved Clinical Outcomes at Lower Cost Versus Standard-of-Care Treatment of Type 1 Diabetes in Sweden: A Cost-Effectiveness Analysis. Diabetes Therapy, 12 (1), 373-388. [BibTeX]
Jendle, J. , Buompensiere, M. I. , Holm, A. L. , de Portu, S. , Malkin, S. J. P. & Cohen, O. (2021). The Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: a Health Economic Analysis in Sweden. Diabetes Therapy, 12 (11), 2977-2991. [BibTeX]
Jendle, J. & Adolfsson, P. (2020). Continuous Glucose Monitoring Diving and Diabetes: An Update of the Swedish Recommendations. Journal of Diabetes Science and Technology, 14 (1), 170-173. [BibTeX]
Andersson, E. , Persson, S. , Hallén, N. , Ericsson, Å. , Thielke, D. , Lindgren, P. , Steen Carlsson, K. & Jendle, J. (2020). Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden. Diabetologia, 63 (12), 2582-2594. [BibTeX]
Persson, S. , Johansen, P. , Andersson, E. , Lindgren, P. , Thielke, D. , Thorsted, B. L. , Jendle, J. & Carlsson, K. S. (2020). Days absent from work due to complications associated with type 2 diabetes: Evidence from 20 years of linked national registry data in Sweden. Diabetes, obesity and metabolism, 22 (9), 1586-1597. [BibTeX]
Groop, P. , Dandona, P. , Phillip, M. , Gillard, P. , Edelman, S. , Jendle, J. , Xu, J. , Scheerer, M. F. & et al. (2020). Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials. The Lancet Diabetes and Endocrinology, 8 (10), 845-854. [BibTeX]
Huhn, E. A. , Linder, T. , Eppel, D. , Weißhaupt, K. , Klapp, C. , Schellong, K. , Henrich, W. , Yerlikaya-Schatten, G. & et al. (2020). Effectiveness of real-time continuous glucose monitoring to improve glycaemic control and pregnancy outcome in patients with gestational diabetes mellitus: a study protocol for a randomised controlled trial. BMJ Open, 10 (11). [BibTeX]
Jendle, J. , Ericsson, Å. , Ekman, B. , Sjöberg, S. , Gundgaard, J. , da Rocha Fernandes, J. , Mårdby, A. , Hunt, B. & et al. (2020). Real-world cost-effectiveness of insulin degludec in type 1 and type 2 diabetes mellitus from a Swedish 1-year and long-term perspective. Journal of Medical Economics, 23 (11), 1311-1320. [BibTeX]
de Valk, H. W. , Feher, M. , Hansen, T. K. , Jendle, J. , Koefoed, M. M. , Rizi, E. P. , Zimmermann, E. & Fadini, G. P. (2020). Switching to Degludec is Associated with Reduced Hypoglycaemia, Irrespective of Definition Used or Patient Characteristics: Secondary Analysis of the ReFLeCT Prospective, Observational Study. Diabetes Therapy, 11 (9), 2159-2167. [BibTeX]
Jendle, J. (2020). The Use of eHealth for the Care of Patients With Diabetes in Connection to the COVID-19 Pandemic. Journal of Diabetes Science and Technology, 14 (4), 739-740. [BibTeX]
Mattsson, S. , Jendle, J. & Adolfsson, P. (2019). Carbohydrate Loading Followed by High Carbohydrate Intake During Prolonged Physical Exercise and Its Impact on Glucose Control in Individuals With Diabetes Type 1-An Exploratory Study. Frontiers in Endocrinology, 10. [BibTeX]
Jendle, J. , Pöhlmann, J. , de Portu, S. , Smith-Palmer, J. & Roze, S. (2019). Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes. Diabetes Technology & Therapeutics, 21 (3), 110-118. [BibTeX]
Jendle, J. & Riddell, M. C. (2019). Editorial: Physical Activity and Type 1 Diabetes. Frontiers in Endocrinology, 10. [BibTeX]
Nyström, T. , Santos-Pardo, I. , Fang, X. , Cao, Y. , Hedberg, F. & Jendle, J. (2019). Heart rate variability in type 2 diabetic subjects randomized to liraglutide or glimepiride treatment, both in combination with metformin: A randomized, open, parallel-group study. Endocrinology, Diabetes & Metabolism, 2 (2). [BibTeX]
Jendle, J. , Birkenfeld, A. L. , Polonsky, W. H. , Silver, R. , Uusinarkaus, K. , Hansen, T. , Håkan-Bloch, J. , Tadayon, S. & et al. (2019). Improved treatment satisfaction in patients with type 2 diabetes treated with once-weekly semaglutide in the SUSTAIN trials. Diabetes, obesity and metabolism, 21 (10), 2315-2326. [BibTeX]
Fadini, G. P. , Feher, M. , Hansen, T. K. , de Valk, H. W. , Koefoed, M. M. , Wolden, M. , Zimmerman, E. & Jendle, J. (2019). Switching to Degludec from Other Basal Insulins is Associated with Reduced Hypoglycemia Rates: a Prospective Study. Journal of Clinical Endocrinology and Metabolism, 104 (12), 5977-5990. [BibTeX]
Jendle, J. , Sandberg, A. , Buchs, S. , Swinburn, P. , Hadi, M. & Levin, L. Å. (2018). A utility valuation study assessing the impact of postprandial glucose control on quality of life of individuals with type 1 or type 2 diabetes. Journal of Patient-Reported Outcomes, 2 (20). [BibTeX]
Jendle, J. , Ericsson, Å. , Hunt, B. , Valentine, W. J. & Pollock, R. F. (2018). Achieving Good Glycemic Control Early After Onset of Diabetes: A Cost-Effectiveness Analysis in Patients with Type 1 Diabetes in Sweden. Diabetes Therapy, 9 (1), 87-99. [BibTeX]
Jendle, J. , Fang, X. , Cao, Y. , Bojö, L. , Nilsson, B. , Hedberg, F. , Santos-Pardo, I. & Nyström, T. (2018). Effects on repetitive 24-hour ambulatory blood pressure in type 2 diabetic subjects randomized to liraglutide or glimepiride treatment both in combination with metformin: A randomized open parallel-group study. Journal of the American Society of Hypertension : JASH, 12 (5), 346-355. [BibTeX]
Nyström, T. , Santos-Pardo, I. , Hedberg, F. , Wardell, J. , Witt, N. , Cao, Y. , Bojö, L. , Nilsson, B. & et al. (2018). Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study (vol 8, 325, 2017). Frontiers in Endocrinology, 9. [BibTeX]
Jendle, J. & Heinemann, L. (2018). Real-Time Continuous Glucose Monitoring Usage in Pilots with Diabetes: An Option to Improve Safety. Diabetes Technology & Therapeutics, 20 (7), 453-454. [BibTeX]
Jendle, J. , Smith-Palmer, J. , Delbaere, A. , de Portu, S. , Papo, N. , Valentine, W. & Roze, S. (2017). Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden. Diabetes Therapy, 8 (5), 1015-1030. [BibTeX]
Mattsson, S. , Adolfsson, P. & Jendle, J. (2017). Diabetes Sports Camps for Individuals with Type 1 Diabetes Associated with Improved Glycemic Control and Self-Estimated Level of Knowledge. Journal of Diabetes Research and Therapy, 3 (2). [BibTeX]
Nyström, T. , Santos, I. P. , Hedberg, F. , Wardell, J. , Witt, N. , Cao, Y. , Bojo, L. , Nilsson, B. & et al. (2017). Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study. Frontiers in Endocrinology, 8. [BibTeX]
Jendle, J. , Rinnert, K. , Westman, A. & Heinemann, L. (2017). Pilots and Diabetes Technology: Functional Health. Journal of Diabetes Science and Technology, 11 (2), 191-194. [BibTeX]
Jendle, J. , Testa, M. A. , Martin, S. , Jiang, H. & Milicevic, Z. (2016). Continuous glucose monitoring in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonist dulaglutide in combination with prandial insulin lispro: an AWARD-4 substudy. Diabetes, obesity and metabolism, 18 (10), 999-1005. [BibTeX]
Ridderstrale, M. , Evans, L. M. , Jensen, H. H. , Bøgelund, M. , Jensen, M. M. , Ericsson, Å. & Jendle, J. (2016). Estimating the impact of changes in HbA(1c), body weight and insulin injection regimen on health related quality-of-life: a time trade off study. Health and Quality of Life Outcomes, 14. [BibTeX]
Roze, S. , Gherardi, A. , de Portu, S. & Jendle, J. (2016). Health-Economic Analysis Of The Use Of Sensor-Augmented Pump With Predictive Suspend Function (Sap) Therapy In Sweden Compared To Insulin Pump Therapy Alone (Csii), In Type 1 Diabetic Patients. Value in Health, 19 (7), A699-A699. [BibTeX]
Jendle, J. H. , Rawshani, A. , Svensson, A. , Avdic, T. & Gudbjörnsdóttir, S. (2016). Indications for Insulin Pump Therapy in Type 1 Diabetes and Associations With Glycemic Control. Journal of Diabetes Science and Technology, 10 (5), 1027-1033. [BibTeX]
Adolfsson, P. , Strömgren, A. , Mattsson, S. , Chaplin, J. E. & Jendle, J. (2015). Education and individualized support regarding exercise and diabetes improves glucose control and level of physical activity in type 1 diabetes individuals. Journal of Endocrinology Diabetes & Obesity, 3 (2), 1071-1077. [BibTeX]
Adolfsson, P. , Mattsson, S. & Jendle, J. (2015). Evaluation of glucose control when a new strategy of increased carbohydrate supply is implemented during prolonged physical exercise in type 1 diabetes. European Journal of Applied Physiology, 115 (12), 2599-2607. [BibTeX]
Roze, S. , Saunders, R. , Brandt, A. -. , de Portu, S. , Papo, N. L. & Jendle, J. (2015). Health-economic analysis of real-time continuous glucose monitoring in people with Type 1 diabetes. Diabetic Medicine, 32 (5), 618-626. [BibTeX]
Steineck, I. , Cederholm, J. , Eliasson, B. , Rawshani, A. , Eeg-Olofsson, K. , Svensson, A. , Zethelius, B. , Avdic, T. & et al. (2015). Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18 168 people with type 1 diabetes: observational study. BMJ-BRITISH MEDICAL JOURNAL, 350. [BibTeX]
Blonde, L. , Jendle, J. , Gross, J. , Woo, V. , Jiang, H. , Fahrbach, J. L. & Milicevic, Z. (2015). Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority study. The Lancet, 385 (9982), 2057-2066. [BibTeX]
Yousef, M. , Westman, A. , Lindberg, A. , de Lacerda, C. & Jendle, J. (2014). Glucose Changes and Working Memory in Individuals with Type 1 Diabetes During Air Pressure Changes Simulating Skydiving. Diabetes Technology & Therapeutics, 16 (1), 56-62. [BibTeX]
Khalili, P. , Sundström, J. , Jendle, J. , Lundin, F. , Jungner, I. & Nilsson, P. M. (2014). Sialic acid and incidence of hospitalization for diabetes and its complications during 40-years of follow-up in a large cohort: The Värmland survey. Primary Care Diabetes, 8 (4), 352-357. [BibTeX]
Freemantle, N. , Meneghini, L. , Christensen, T. , Wolden, M. L. , Jendle, J. & Ratner, R. (2013). Insulin degludec improves health-related quality of life (SF-36(®) ) compared with insulin glargine in people with Type 2 diabetes starting on basal insulin: a meta-analysis of phase 3a trials. Diabetic Medicine, 30 (2), 226-232. [BibTeX]
Khalili, P. , Sundström, J. , Franklin, S. S. , Jendle, J. , Lundin, F. , Jungner, I. & Nilsson, P. M. (2012). Combined effects of brachial pulse pressure and sialic acid for risk of cardiovascular events during 40 years of follow-up in 37 843 individuals. Journal of Hypertension, 30 (9), 1718-1724. [BibTeX]
Adolfsson, P. , Örnhagen, H. , Eriksson, B. M. , Cooper, K. & Jendle, J. (2012). Continuous glucose monitoring: a study of the Enlite sensor during hypo- and hyperbaric conditions. Diabetes Technology & Therapeutics, 14 (6), 527-532. [BibTeX]
Valentine, W. J. , Jendle, J. , Saraheimo, M. , Thorsteinsson, B. , Pollock, R. F. & Lammert, M. (2012). Evaluating the cost-effectiveness of reduced mild hypoglycaemia in subjects with Type 1 diabetes treated with insulin detemir or NPH insulin in Denmark, Sweden, Finland and the Netherlands. Diabetic Medicine, 29 (3), 303-312. [BibTeX]
Lind, M. , Jendle, J. , Torffvit, O. & Lager, I. (2012). Glucagon-like peptide 1 (GLP-1) analogue combined with insulin reduces HbA1c and weight with low risk of hypoglycemia and high treatment satisfaction. Primary Care Diabetes, 6 (1), 41-46. [BibTeX]
Home, P. D. , Meneghini, L. , Wendisch, U. , Ratner, R. E. , Johansen, T. , Christensen, T. E. , Jendle, J. , Roberts, A. P. & et al. (2012). Improved health status with insulin degludec compared with insulin glargine in people with Type 1 diabetes. Diabetic Medicine, 29 (6), 716-720. [BibTeX]
Adolfsson, P. , Ornhagen, H. , Eriksson, B. M. , Gautham, R. & Jendle, J. (2012). In-vitro performance of the Enlite sensor in various glucose concentrations during hypobaric and hyperbaric conditions. Journal of Diabetes Science and Technology, 6 (6), 1375-1382. [BibTeX]
Jendle, J. , Christensen, J. H. , Kvistgaard, H. , Gregersen, N. & Rittig, S. (2012). Late-onset familial neurohypophyseal diabetes insipidus due to a novel mutation in the AVP gene. Clinical Endocrinology, 77 (4), 586-592. [BibTeX]
Jendle, J. , Alvarsson, M. , Hanås, R. & Attvall, S. (2012). Mätning av blodketoner [Measuring blood ketones]: när, var och hur [when, where and how]. Läkartidningen, 109 (45), 2031-2032. [BibTeX]
Jendle, J. , Adolfsson, P. & Ornhagen, H. (2012). Swedish recommendations on recreational diving and diabetes mellitus. Diving and Hyperbaric Medicine, 42 (4), 231-233. [BibTeX]
Jendle, J. , Torffvit, O. , Ridderstråle, M. , Ericsson, Å. , Nilsen, B. & Bøgelund, M. (2012). Willingness to pay for diabetes drug therapy in type 2 diabetes patients: based on LEAD clinical programme results. Journal of Medical Economics, 15 (Suppl 2), 1-5. [BibTeX]
Jendle, J. , Ridderstråle, M. , Torfvitt, O. , Ericsson, Å. & Larsen, S. (2012). Willingness-to-pay for benefits associated with basal insulin treatment of type 2 diabetes. Journal of Medical Economics, 15 (2), 261-263. [BibTeX]
Jendle, J. , Adolfsson, P. , Attvall, S. & Örnhagen, H. (2011). Dykning vid diabetes möjligt men inte riskfritt [Diving in diabetes possible but not without risks]. Läkartidningen, 108 (44), 2230-2231. [BibTeX]
Jendle, J. & Adolfsson, P. (2011). Impact of high altitudes on glucose control. Journal of Diabetes Science and Technology, 5 (6), 1621-1622. [BibTeX]
Birkeland, K. I. , Home, P. D. , Wendisch, U. , Ratner, R. E. , Johansen, T. , Endahl, L. A. , Lyby, K. , Jendle, J. & et al. (2011). Insulin degludec in type 1 diabetes: a randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine. Diabetes Care, 34 (3), 661-665. [BibTeX]
Faerch, M. , Corydon, T. J. , Rittig, S. , Christensen, J. H. , Hertz, J. M. & Jendle, J. (2010). Skewed X-chromosome inactivation causing diagnostic misinterpretation in congenital nephrogenic diabetes insipidus. Scandinavian Journal of Urology and Nephrology, 44 (5), 324-330. [BibTeX]
Khalili, P. , Flyvbjerg, A. , Frystyk, J. , Lundin, F. , Jendle, J. , Engström, G. & Nilsson, P. M. (2010). Total adiponectin does not predict cardiovascular events in middle-aged men in a prospective, long-term follow-up study. Diabetes & Metabolism, 36 (2), 137-143. [BibTeX]
Jendle, J. , Torffvit, O. , Ridderstråle, M. , Lammert, M. , Ericsson, Å. & Bøgelund, M. (2010). Willingness to pay for health improvements associated with anti-diabetes treatments for people with type 2 diabetes. Current Medical Research and Opinion, 26 (4), 917-923. [BibTeX]
Adolfsson, P. , Örnhagen, H. & Jendle, J. (2009). Accuracy and reliability of continuous glucose monitoring in individuals with type 1 diabetes during recreational diving. Diabetes Technology & Therapeutics, 11 (8), 493-497. [BibTeX]
Jendle, J. (2009). Resource utilisation and costs for the treatment of diabetes in the developed world: an economical burden that needs to be solved. International journal of clinical practice (Esher), 63 (7), 980-982. [BibTeX]
Jendle, J. , Nauck, M. A. , Matthews, D. R. , Frid, A. , Hermansen, K. , During, M. , Zdravkovic, M. , Strauss, B. J. & et al. (2009). Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue. Diabetes, obesity and metabolism, 11 (12), 1163-1172. [BibTeX]
Goodall, G. , Jendle, J. , Valentine, W. J. , Munro, V. , Brandt, A. B. , Ray, J. A. , Roze, S. , Foos, V. & et al. (2008). Biphasic insulin aspart 70/30 vs. insulin glargine in insulin naïve type 2 diabetes patients: modelling the long-term health economic implications in a Swedish setting. International journal of clinical practice (Esher), 62 (6), 869-876. [BibTeX]
Adolfsson, P. , Örnhagen, H. & Jendle, J. (2008). The benefits of continuous glucose monitoring and a glucose monitoring schedule in individuals with type 1 diabetes during recreational diving. Journal of Diabetes Science and Technology, 2 (5), 778-784. [BibTeX]
Jendle, J. & Norberg, B. (2007). Kliniska erfarenheter av behandling med Levemir [Clinical experiences with Levemir treatment].. Läkartidningen, 104 (1-2), 54-54. [BibTeX]
Kølendorf, K. , Ross, G. P. , Pavlic-Renar, I. , Perriello, G. , Philotheou, A. , Jendle, J. , Gall, M. & Heller, S. R. (2006). Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes. Diabetic Medicine, 23 (7), 729-735. [BibTeX]
Himmelmann, A. , Jendle, J. , Mellén, A. , Petersen, A. H. , Dahl, U. L. & Wollmer, P. (2003). The impact of smoking on inhaled insulin. Diabetes Care, 26 (3), 677-682. [BibTeX]
Brunner, G. A. , Balent, B. , Ellmerer, M. , Schaupp, L. , Siebenhofer, A. , Jendle, J. , Okikawa, J. & Pieber, T. R. (2001). Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients.. Diabetologia, 44 (3), 305-308. [BibTeX]
Lundström, A. , Jendle, J. , Stenström, B. , Toss, G. & Ravald, N. (2001). Periodontal conditions in 70-year-old women with osteoporosis. Swedish Dental Journal, 25 (3), 89-96. [BibTeX]
Jendle, J. , Karlberg, B. E. & Arborelius, M. (1996). An exploration of intrapulmonary insulin administration in anaesthetized and mechanically ventilated pigs. Scandinavian Journal of Clinical and Laboratory Investigation, 56 (3), 251-258. [BibTeX]
Jendle, J. & Karlberg, B. E. (1996). Effects of intrapulmonary insulin in patients with non-insulin-dependent diabetes. Scandinavian Journal of Clinical and Laboratory Investigation, 56 (6), 555-561. [BibTeX]
Jendle, J. & Karlberg, B. E. (1996). Intrapulmonary administration of insulin to healthy volunteers. Journal of Internal Medicine, 240 (2), 93-98. [BibTeX]
Jendle, J. , Karlberg, B. E. , Persliden, J. , Franzén, L. & Arborelius, M. (1995). Delivery and Retention of an Insulin Aerosol Produced by a New Jet Nebulizer. Journal of Aerosol Medicine, 8 (3), 243-254. [BibTeX]
Nilsson, L. , Nilsson, M. & Jendle, J. (1988). Subpopulations of variants resistant to imipenem in Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy, 22 (5), 643-649. [BibTeX]

Articles, reviews/surveys

Jendle, J. , Adolfsson, P. , Choudhary, P. , Dovc, K. , Fleming, A. , Klonoff, D. C. , Mader, J. K. , Oliver, N. & et al. (2024). A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspective. Diabetologia, 67 (2), 236-245. [BibTeX]
Adolfsson, P. , Hanas, R. , Zaharieva, D. P. , Dovc, K. & Jendle, J. (2024). Automated Insulin Delivery Systems in Pediatric Type 1 Diabetes: A Narrative Review. Journal of Diabetes Science and Technology, 18 (6), 1324-1333. [BibTeX]
von Kobyletzki, L. B. , Ulriksdotter, J. , von Kobyletzki, E. , Mowitz, M. , Jendle, J. & Svedman, C. (2024). Insulin Pump Therapy and Adverse Skin Reactions With Focus on Allergic Contact Dermatitis in Individuals Living With Diabetes Mellitus: A Systematic Review and Clinical-Based Update. Journal of Diabetes Science and Technology, 18 (6), 1300-1312. [BibTeX]
Freckmann, G. , Eichenlaub, M. , Waldenmaier, D. , Pleus, S. , Wehrstedt, S. , Haug, C. , Witthauer, L. , Jendle, J. & et al. (2023). Clinical Performance Evaluation of Continuous Glucose Monitoring Systems: A Scoping Review and Recommendations for Reporting. Journal of Diabetes Science and Technology, 17 (6), 1506-1526. [BibTeX]
Garcia-Argibay, M. , Li, L. , Du Rietz, E. , Zhang, L. , Yao, H. , Jendle, J. , Ramos-Quiroga, J. A. , Ribasés, M. & et al. (2023). The association between type 2 diabetes and attention- deficit/hyperactivity disorder: a systematic review, meta-analysis, and population-based sibling study. Neuroscience and Biobehavioral Reviews, 147. [BibTeX]
Jendle, J. & Reznik, Y. (2023). Use of insulin pumps and closed-loop systems among people living with diabetes: A narrative review of clinical and cost-effectiveness to enable access to technology and meet the needs of payers. Diabetes, obesity and metabolism, 25 (Sup. 2), 21-32. [BibTeX]
Jendle, J. , Landin, B. , Jansson, S. P. O. & Nordin, G. (2020). När HbA1c inte stämmer: Olika metoder kan ge olika resultat – och ibland kan även resultat som stämmer överens ge fel bild av glukosbalansen. Läkartidningen, 117 (37). [BibTeX]
Jendle, J. , Adolfsson, P. & Pollock, N. W. (2020). Recreational diving in persons with type 1 and type 2 diabetes: Advancing capabilities and recommendations. Diving and Hyperbaric Medicine, 50 (2), 135-143. [BibTeX]
Jendle, J. , Grunberger, G. , Blevins, T. , Giorgino, F. , Hietpas, R. T. & Botros, F. T. (2016). Efficacy and Safety of Dulaglutide in the Treatment of Type 2 Diabetes: A Comprehensive Review of the Dulaglutide Clinical Data Focusing on the AWARD Phase 3 Clinical Trial Program. Diabetes/Metabolism Research Reviews, 32 (8), 776-790. [BibTeX]
Jendle, J. , Martin, S. A. & Milicevic, Z. (2012). Insulin and GLP-1 analog combinations in type 2 diabetes mellitus: a critical review. Expert Opinion on Investigational Drugs, 21 (10), 1463-1474. [BibTeX]

Books

Venizelos, N. , Sirsjö, A. , Ericsson, E. , Johansson, M. , Hjelmqvist, H. , Jendle, J. , Eriksson, M. , Karlsson, M. & et al. Venizelos, N. (ed.) , Sirsjö, A. (ed.) , Ericsson, E. (ed.) , Johansson, M. (ed.) , Hjelmqvist, H. (ed.) , Jendle, J. (ed.) , Eriksson, M. (ed.) , Karlsson, M. (ed.) & Möller, M. (ed.) (2018). Örebro University’s Nobel Day Festivities: Book of abstracts, 2018. Örebro: Örebro universitet. [BibTeX]

Chapters in books

Jendle, J. & Törnberg, Å. (2021). Fysisk aktivitet vid typ 1 diabetes. In: Ing-Mari Dohrn, Eva Jansson Mats Börjesson, Maria Hagströmer, Fysisk aktivitet i sjukdomsprevention och sjukdomsbehandling, FYSS 2021 (pp. 325-330). Stockholm: Läkartidningen Förlag AB. [BibTeX]
Jendle, J. & Törnberg, Å. (2021). Fysisk aktivitet vid typ 2 diabetes. In: Ing-Mari Dohrn, Eva Jansson Mats Börjesson, Maria Hagströmer, Fysisk aktivitet i sjukdomsprevention och sjukdomsbehandling, FYSS 2021 (pp. 331-336). Stockholm: Läkartidningen Förlag AB. [BibTeX]
Jendle, J. (2020). Insulinbehandling. In: Mona Landin Olsson, Diabetes (pp. 107-118). Lund: Studentlitteratur AB. [BibTeX]
Jendle, J. (2016). Diabetes Melitus: Typ 1-diabetes, Typ 2-diabetes. In: Maria Hagströmer, Eva Jansson, FYSS 2017: Fysisk aktivitet i sjukdomsprevention och sjukdomsbehandling (pp. 371-390). Stockholm: Läkartidningen Förlag AB. [BibTeX]

Collections (editor)

Jendle, J. (ed.) , Riddell, M. C. (ed.) & Jones, T. W. (ed.) (2019). Physical Activity and Type 1 Diabetes (1ed.). Lausanne: Frontiers Media S.A.. [BibTeX]

Conference papers

Jendle, J. , Buompensiere, M. I. , Saltik, A. Z. O. & Cohen, O. (2023). COST-EFFECTIVENESS ANALYSIS OF THE MINIMED (TM) 780G SYSTEM VERSUS MULTIPLE DAILY INJECTIONS WITH INTERMITTENTLY SCANNED CONTINUOUS GLUCOSE MONITORING IN INDIVIDUALS WITH TYPE1 DIABETES ACROSS EUROPE. In: Diabetes Technology & Therapeutics. Paper presented at Advanced Technologies & Treatments for Diabetes Conference, Berlin, Germany, February 22-25, 2023. (pp. A119-A119). Mary Ann Liebert. [BibTeX]
Menzen, M. , Hartvig, N. V. , Kaas, A. , Knudsen, N. & Jendle, J. (2023). FACTORS AFFECTING BASAL INSULIN INJECTION ADHERENCE INVESTIGATED USING SMART INSULIN PEN DATA. In: Diabetes Technology & Therapeutics. Paper presented at Advanced Technologies & Treatments for Diabetes Conference, Berlin, Germany, February 22-25, 2023. (pp. A197-A197). Mary Ann Liebert. [BibTeX]
Sharif, A. , Jendle, J. & Hellgren, K. (2023). Inter-observer Reliability of Counting Retinal Microaneurysms and Haemorrhages in Elderly with Diabetes. In: European Journal of Ophthalmology. Paper presented at 33rd European Association for Diabetic Eye Complications Conference (EAsDEC 2023), Coimbra, Portugal, June 1–3, 2023. (pp. 20-20). Sage Publications. [BibTeX]
Jendle, J. , Agvall, B. , Galozy, A. & Adolfsson, P. (2022). BETTER GLYCEMIC CONTROL AND HIGHER USE OF ADVANCED DIABETES TECHNOLOGY IN AGE GROUP 0-17 YRS COMPARED TO 18-25 YRS WITH TYPE 1 DIABETES. In: Diabetes Technology & Therapeutics. Paper presented at 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2022), Barcelona, Spain, April 27-30, 2022. (pp. A127-A127). Mary Ann Liebert. [BibTeX]
Hellman, J. , Hartvig, N. V. , Kaas, A. , Møller, J. B. , Sørensen, M. R. & Jendle, J. (2022). INFLUENCE OF BOLUS INJECTION DOSING FREQUENCY AND SMART PEN ENGAGEMENT ON GLYCAEMIC CONTROL IN PATIENTS WITH TYPE 1 DIABETES. In: Diabetes Technology & Therapeutics. Paper presented at 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2022), Barcelona, Spain, April 27-30, 2022. (pp. A64-A65). Mary Ann Liebert. [BibTeX]
Coaquira, C. J. , De Pouvourville, G. , Greenberg, D. , Harris, S. , Jendle, J. , Shaw, J. E. , Levrat, G. F. & Szafranski, K. (2022). INTERNAL, EXTERNAL, AND CROSS-VALIDATION OF THE DEDUCE MODEL, A COST-UTILITY TOOL USING PATIENT-LEVEL MICROSIMULATION TO EVALUATE SENSOR-BASED GLUCOSE MONITORING SYSTEMS IN TYPE 1 AND TYPE 2 DIABETES. In: Value in Health. Paper presented at ISPOR Europe 2022, Vienna, Austria, November 6-9, 2022. (pp. S11-S11). ELSEVIER SCIENCE INC. [BibTeX]
Persson, S. , Nilsson, K. , Karlsdotter, K. , Skogsberg, J. , Gustavsson, S. , Jendle, J. & Carlsson, K. S. (2021). Burden of established cardiovascular disease in people with type 2 diabetes and matched controls: hospital-based care, days absent from work, costs, and mortality. In: Diabetologia. Paper presented at 57th EASD Annual Meeting of the European Association for the Study of Diabetes, September 27 – October 1, 2021. (pp. 17-17). Springer. [BibTeX]
Cohen, O. , Holm, A. L. , Buompensiere, M. I. & Jendle, J. (2021). COST-EFFECTIVENESS ANALYSIS OF THE MINIMED (TM) 780G SYSTEM VERSUS MULTIPLE DAILY INJECTIONS WITH INTERMITTENTLY SCANNED CONTINUOUS GLUCOSE MONITORING IN INDIVIDUALS WITH TYPE 1 DIABETES IN SWEDEN. In: Diabetes Technology & Therapeutics. Paper presented at ATTD Advanced Technologies & Treatments for Diabetes Conference, (Virtual conference), June 2-5, 2021. (pp. A81-A81). Mary Ann Liebert. [BibTeX]
Carlsson, K. S. , Andersson, E. , Persson, S. , Hallén, N. , Ericsson, Å. , Thielke, D. , Lindgren, P. & Jendle, J. (2020). Costs of diabetes complications: hospital based care and production loss for 392,200 people with type 2 diabetes and matched controls in Sweden. In: Diabetologia. Paper presented at 56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD 2020 Virtual), September 21-25, 2020. (pp. S121-S121). Springer. [BibTeX]
Hunt, B. , Ericsson, Å. , Gundgaard, J. , Møller, J. B. , Valentine, W. J. & Jendle, J. (2020). Evaluating the long-term cost-effectiveness of introducing a smart insulin pen in standard-of-care treatment of type 1 diabetes in Sweden. In: Diabetologia. Paper presented at 56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD 2020 Virtual), September 21-25, 2020. (pp. S381-S381). Springer. [BibTeX]
Catrina, S. , Hartvig, N. , Kaas, A. , Møller, J. , Mårdby, A. -. & Jendle, J. (2020). Type 1 diabetes: analysis of real-world insulin injection patterns. In: Diabetologia. Paper presented at 56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD 2020 Virtual), September 21-25, 2020. (pp. S378-S378). Springer. [BibTeX]
Jendle, J. , de Portu, S. & Roze, S. (2019). Cost effectiveness analysis of MiniMed 670G system versus continuous subcutaneous insulin infusion, in individuals with type 1 diabetes. Paper presented at ATTD 2019, Berlin, Germany, 20-23 February, 2019. [BibTeX]
Jendle, J. , Edelman, S. , Dandona, P. , Mathieu, C. , Thoren, F. , Scheerer, J. , Xu, J. & Langkilde, A. (2019). Dapagliflozin as an adjunct to insulin on urinary albumin-to creatinine ratio over 52 weeks in adults with type 1 diabetes. Paper presented at ATTD 2019, Berlin, Germany, 20-23 February, 2019. [BibTeX]
Jendle, J. , Edelman, S. , Dandona, P. , Mathieu, C. , Thoren, F. A. , Scheerer, M. F. , Xu, J. & Langkilde, A. M. (2019). EFFECT OF ADDING DAPAGLIFLOZIN AS AN ADJUNCT TO INSULIN ON URINARY ALBUMIN-TO-CREATININE RATIO OVER 52 WEEKS IN ADULTS WITH TYPE 1 DIABETES. In: Diabetes Technology & Therapeutics. Paper presented at Advanced Technologies & Treatments for Diabetes Conference (ATTD), Berlin, Germany, February 20–23, 2019. (pp. A136-A137). Mary Ann Liebert. [BibTeX]
Lahtela, J. , Edelman, S. , Jendle, J. , Dandona, P. , Mathieu, C. , Thorén, F. , Scheerer, M. , Xu, J. & et al. (2019). Effect of adding dapagliflozin as an adjunct to insulin on urinary albumin-to-creatinine ratio over 52 weeks in adults with type 1 diabetes. Paper presented at 55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD 2019), Barcelona, Spain, September 16-20, 2019. (pp. S342-S342). Springer. [BibTeX]
Feher, M. , Fadini, G. , Krarup Hansen, T. , Jendle, J. , Merchante, A. , Koefoed, M. , Rizi, E. , Zimmermann, E. & et al. (2019). Hypoglycaemia, irrespective of the definition used, is reduced when switching to insulin degludec from other basal insulins in routine clinical care: The ReFLeCT study. Paper presented at 55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD 2019), Barcelona, Spain, September 16-20, 2019. (pp. S385-S385). Springer. [BibTeX]
Jendle, J. , Thunander, M. , Sjöberg, S. , Ekman, B. , Mårdby, A. , da Rocha Fernandes, J. D. , Gundgaard, J. & Ericsson, Å. (2019). Real-world cost-effectiveness of insulin degludec in type 1 and type 2 diabetes in a Swedish setting. Paper presented at 55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD 2019), Barcelona, Spain, September 16-20, 2019. (pp. S436-S436). Springer. [BibTeX]
Fadini, G. P. , Feher, M. , Hansen, T. K. , de Valk, H. W. , Koefoed, M. M. , Wolden, M. , Zimmermann, E. & Jendle, J. (2019). Reduced rates of overall hypoglycaemia in patients with Type 1 diabetes after switching to insulin degludec: A European, multinational, multicentre, prospective, observational study (ReFLeCT). In: Diabetic Medicine. Paper presented at Diabetes UK Professional Conference 2019, Liverpool, UK, March 6-8, 2019. (pp. 60-60). John Wiley & Sons. [BibTeX]
de Valk, H. , Feher, M. , Krarup Hansen, T. , Jendle, J. , Merchante, A. , Koefoed, M. , Rizi, E. , Zimmermann, E. & et al. (2019). Switching to insulin degludec from other basal insulins reduces rates of hypoglycaemia across patient subgroups in routine clinical care: The ReFLeCT study. Paper presented at EASD 2019, Barcelona, Spain, 16-20 September, 2019. [BibTeX]
de Valk, H. , Feher, M. , Krarup Hansen, T. , Jendle, J. , Merchante, A. , Koefoed, M. , Rizi, E. , Zimmermann, E. & et al. (2019). Switching to insulin degludec from other basal insulins reduces rates of hypoglycemia (according to different definitions) in routine clinical care: The ReFLeCT Study. Paper presented at ADA 2019, San Francisco, CA, USA, 7-11 June, 2019. [BibTeX]
de Valk, H. , Feher, M. , Krarup Hansen, T. , Jendle, J. , Merchante, A. , Koefoed, M. , Rizi, E. , Zimmermann, E. & et al. (2019). Switching to insulin degludec from other basal insulins reduces rates of hypoglycemia across patient subgroups in routine clinical care: The ReFleCT study. Paper presented at ADA2019, San Francisco, CA, USA, 7-11 June, 2019. [BibTeX]
Jendle, J. , Thunander, M. , Ekman, B. , Sjöberg, S. , Ericsson, Å. , da Rocha Fernandes, J. , Mårdby, A. , Malkin, S. & et al. (2019). Switching to insulin degludec is a cost-saving therapy for patients with type 1 and type 2 diabetes in the Swedish setting based on real world data. In: Value in Health. Paper presented at ISPOR 2019, Copenhagen, Denmark, November 2-6, 2019. (pp. 575-576). Elsevier. [BibTeX]
Sharif, A. , Jendle, J. & Hellgren, K. J. (2018). Compliance to Screening of Diabetic Retinopathy with 18 to 36 Months Interval. In: European Journal of Ophthalmology. Sage Publications. [BibTeX]
Galavazi, M. , Jansson, S. P. O. , Jendle, J. & Karlsson, J. (2018). Long-term effects of low energy diet combined with CBT-based group treatment of patients with obesity on weight, quality of life and eating behaviour: a 2-year intervention study. Paper presented at IOB, Vienna, Austria, 2018. [BibTeX]
Jendle, J. , Birkenfeld, A. L. , Silver, R. , Uusinarkaus, K. , Højbjerre, L. , Thomsen, H. F. & Davies, M. (2017). Effect of Gastrointestinal Adverse Events on Treatment Satisfaction in Semaglutide Treatment of Type 2 Diabetes. In: Value in Health. Elsevier. [BibTeX]
Klinkenbijl, B. , Jendle, J. , Chaugule, S. & Graham, C. (2017). Evaluation Of The Long-Term Cost-Effectiveness Of Real Time Continuous Glucose Monitoring (Rtcgm) Versus Self Monitoring Of Blood Glucose (Smbg) Alone In Type 1 Diabetes From The Swedish Societal Perspective. In: Value in Health. Paper presented at ISPOR 2107. (pp. A585-A585). Elsevier. [BibTeX]
Jendle, J. , Testa, M. , Martin, S. , Jiang, H. & Milicevic, Z. (2015). Continuous glucose monitoring in type 2 diabetes patients treated with once weekly dulaglutide or once daily glargine, both combined with insulin lispro (AWARD-4 substudy). In: Diabetologia. Paper presented at 51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Stockholm, Sweden, September 14-18, 2015. (pp. S38-S38). [BibTeX]
Jendle, J. , Ridderstrale, M. , Jensen, H. H. , Bøgelund, M. , Jensen, M. M. , Ericsson, A. & Evans, M. (2015). Investigating the short-term impact of poor glycemic control on the daily lives of people with type 2 diabetes. In: Value in Health. [BibTeX]
Evans, M. , Ridderstråle, M. , Jensen, H. H. , Bøgelund, M. , Jensen, M. M. , Ericsson, Å. & Jendle, J. (2015). Quantifying The Short-Term Impact of Changes In Hba1c, Weight And Insulin Regimen on Health Related Quality-of-Life. In: Value in Health. Elsevier. [BibTeX]
Jendle, J. , Blonde, L. , Rosenstock, J. , Woo, V. , Gross, J. , Jiang, H. & Milicevic, Z. (2014). Better glycaemic control and less weight gain with once weekly dulaglutide vs bedtime insulin glargine, both combined with thrice daily lispro, in type 2 diabetes (AWARD-4). In: Diabetologia. [BibTeX]

Manuscripts

Khalili, P. , Sundström, J. , Jendle, J. , Jungner, I. & Nilsson, P. M. Siliac-acid and incidence of hospitalization for diabetes and its complications during 40-years of follow-up in a large cohort : the Värmland survey. [BibTeX]